Point-of-care testing (POCT) of patients with a high concentration of uric acid by using alginate hydrogel microspheres embedded with CdZnTeS QDs and urate oxidase (Alg@QDs-UOx MSs)

The Analyst ◽  
2021 ◽  
Author(s):  
Fan Lu ◽  
Yeling Yang ◽  
Yucheng Liu ◽  
Fubing Wang ◽  
Xinghu Ji ◽  
...  

A more convenient method for POCT of patients with a high concentration of uric acid by using Alg@QDs-UOx MSs is developed.

2019 ◽  
Vol 43 (20) ◽  
pp. 7636-7645 ◽  
Author(s):  
Muhsin Ali ◽  
Muhammad Asad Ullah Khalid ◽  
Imran Shah ◽  
Soo Wan Kim ◽  
Young Su Kim ◽  
...  

A colorimetric portable setup was developed for remote UA measurements using a smartphone-based application to demonstrate its use in point-of-care testing.


2020 ◽  
Vol 92 (24) ◽  
pp. 15699-15704
Author(s):  
Ya-Jie Zhang ◽  
Lan Guo ◽  
Yong-Liang Yu ◽  
Jian-Hua Wang

2020 ◽  
Vol 27 ◽  
Author(s):  
Yi Zhang

: Point-of-care (POC) testing decentralizes the diagnostic tests to the sites near the patient. Many POC tests rely microfluidic platforms for sample-to-answer analysis. Compared to other microfluidic systems, magnetic digital microfluidics demonstrate compelling advantages for POC diagnostics. In this review, we have examined the capability of magnetic digital microfluidics-based POC diagnostic platforms. More importantly, we have categorized POC settings into three classes based on “where is the point”, “who to care” and “how to test”, and evaluated the suitability of magnetic digital microfluidics in various POC settings. Furthermore, we have addressed other technical issues associated with POC testing such as controlled environment, sample-system interface, system integration and information connectivity. We hope this review would provide a guideline for the future development of magnetic digital microfluidics-based platforms for POC testing.


Sign in / Sign up

Export Citation Format

Share Document